16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene

C43H30N4 — CID 145276785

IUPAC16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene
SMILESCC1C=CC(c2nc(-n3c4ccccc4c4cc5c(ccc6c7ccccc7n(-c7ccccc7)c56)cc43)nc3ccccc23)=CC1
InChIInChI=1S/C43H30N4/c1-27-19-21-28(22-20-27)41-34-15-5-8-16-37(34)44-43(45-41)47-39-18-10-7-14-32(39)36-26-35-29(25-40(36)47)23-24-33-31-13-6-9-17-38(31)46(42(33)35)30-11-3-2-4-12-30/h2-19,21-27H,20H2,1H3
InChIKeyBVERLYVZMKODKL-UHFFFAOYSA-N
MW602.74 g/mol
LogP10.96
Rot. Bonds3

About 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene

16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene (PubChem CID 145276785) has the molecular formula C43H30N4 and a molecular weight of 602.74 g/mol. Its IUPAC name is 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene.

Molecular Properties

Compound Name16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene
PubChem CID145276785
Molecular FormulaC43H30N4
Molecular Weight602.74 g/mol
Exact Mass602.25
IUPAC Name16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene
SMILESCC1C=CC(c2nc(-n3c4ccccc4c4cc5c(ccc6c7ccccc7n(-c7ccccc7)c56)cc43)nc3ccccc23)=CC1
InChIInChI=1S/C43H30N4/c1-27-19-21-28(22-20-27)41-34-15-5-8-16-37(34)44-43(45-41)47-39-18-10-7-14-32(39)36-26-35-29(25-40(36)47)23-24-33-31-13-6-9-17-38(31)46(42(33)35)30-11-3-2-4-12-30/h2-19,21-27H,20H2,1H3
InChIKeyBVERLYVZMKODKL-UHFFFAOYSA-N
XLogP10.96
TPSA35.64 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds3
Heavy Atoms47
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500602.74
LogP ≤ 510.96
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Analyze 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene?
The IUPAC name of 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene (CID 145276785) is 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene.
What is the SMILES notation for 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene?
The canonical SMILES for 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene is CC1C=CC(c2nc(-n3c4ccccc4c4cc5c(ccc6c7ccccc7n(-c7ccccc7)c56)cc43)nc3ccccc23)=CC1.
What is the InChIKey of 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene?
The InChIKey is BVERLYVZMKODKL-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H30N4/c1-27-19-21-28(22-20-27)41-34-15-5-8-16-37(34)44-43(45-41)47-39-18-10-7-14-32(39)36-26-35-29(25-40(36)47)23-24-33-31-13-6-9-17-38(31)46(42(33)35)30-11-3-2-4-12-30/h2-19,21-27H,20H2,1H3.
What are the key properties of 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene?
16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene has a molecular weight of 602.74 g/mol, XLogP of 10.96, 3 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 16-[4-(4-methylcyclohexa-1,5-dien-1-yl)quinazolin-2-yl]-3-phenyl-3,16-diazahexacyclo[11.11.0.02,10.04,9.015,23.017,22]tetracosa-1(24),2(10),4,6,8,11,13,15(23),17,19,21-undecaene is sourced from PubChem (CID 145276785), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).